AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,256.00p
   
  • Change Today:
      12.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.32m
  • Volume: 3,826,293
  • Market Cap: £159,000m
  • RiskGrade: 123
  • Beta: 0.87

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
22-Nov-24 JP Morgan Cazenove Overweight 10,474.00p - 14,000.00p Reiteration
07-Nov-24 Shore Capital Buy 9,725.00p - - Reiteration
03-Sep-24 Deutsche Hold 13,190.00p - 11,000.00p Reiteration
02-Sep-24 Berenberg Bank Buy 13,276.00p - 15,000.00p Reiteration
02-Jul-24 Jefferies Hold 12,086.00p 71.00p 74.00p Reiteration
28-May-24 Citigroup Buy 12,028.00p - - Reiteration
08-Apr-24 Barclays Overweight 10,610.00p - 12,500.00p Reiteration
12-Feb-24 UBS Sell 9,501.00p 10,700.00p 9,900.00p Reiteration
12-Feb-24 Stifel Buy 9,501.00p 125.00p 120.00p Reiteration
12-Feb-24 BMO Capital Markets Outperform 9,501.00p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,256.00p
Change Today 12.00p
% Change 0.12 %
52 Week High 13,276.00
52 Week Low 9,501.00
Volume 3,826,293
Shares Issued 1,550.32m
Market Cap £159,000m
Beta 0.87
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.55% below the market average89.55% below the market average89.55% below the market average89.55% below the market average89.55% below the market average
76% below the sector average76% below the sector average76% below the sector average76% below the sector average76% below the sector average
Price Trend
24.98% below the market average24.98% below the market average24.98% below the market average24.98% below the market average24.98% below the market average
46.94% above the sector average46.94% above the sector average46.94% above the sector average46.94% above the sector average46.94% above the sector average
Income
81.55% below the market average81.55% below the market average81.55% below the market average81.55% below the market average81.55% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
90.08% above the market average90.08% above the market average90.08% above the market average90.08% above the market average90.08% above the market average
93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average

What The Brokers Say

Strong Buy 9
Buy 14
Neutral 6
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-24 22-Feb-24
Paid 09-Sep-24 25-Mar-24
Amount 100.00¢ 197.00¢

Trades for 20-Dec-2024

Time Volume / Share Price
15:07 0 @ 10,202.00p
19:02 120,000 @ 10,222.00p
15:05 0 @ 10,206.00p
15:05 1 @ 10,206.00p
14:59 0 @ 10,184.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page